CARLSMED, INC. 8-K

What Happened
On May 5, 2026, Carlsmed, Inc. (NASDAQ: CARL) filed a Form 8‑K announcing its financial results for the quarter ended March 31, 2026 and furnished a press release as Exhibit 99.1. The 8‑K states the press release is incorporated by reference; the filing is signed by Michael Cordonnier, Chief Executive Officer and President.

Key Details

• Form 8‑K filed on May 5, 2026 under Item 2.02 (Results of Operations and Financial Condition).
• Financial results cover the quarter ended March 31, 2026 (quarterly results / earnings announcement).
• Press release containing the full results is furnished as Exhibit 99.1 and incorporated by reference.
• Filing signed by Michael Cordonnier, CEO and President.

Why It Matters
This filing notifies investors that Carlsmed released its latest quarterly earnings and related financial metrics. The 8‑K itself does not list the numeric results — investors should read the Exhibit 99.1 press release (available on the SEC EDGAR site or the company’s investor relations page) to see revenue, net income/loss, cash position, and any commentary that could affect the stock.